aica ribonucleotide has been researched along with Leukemia, Myeloid, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Han, F; Qu, H; Ren, L; Yan, H; Yang, S | 1 |
| Banfic, H; Dembitz, V; Lalic, H; Lukinovic-Skudar, V; Visnjic, D | 1 |
2 other study(ies) available for aica ribonucleotide and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Combination therapy with 5-amino-4-imidazolecarboxamide riboside and arsenic trioxide in acute myeloid leukemia cells involving AMPK/TSC2/mTOR pathway.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; HL-60 Cells; Humans; Hypoglycemic Agents; Leukemia, Myeloid, Acute; Oxides; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Ribonucleotides; Signal Transduction; TOR Serine-Threonine Kinases; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins | 2013 |
5-Aminoimidazole-4-carboxamide ribonucleoside induces differentiation of acute myeloid leukemia cells.
Topics: Aminoimidazole Carboxamide; Apoptosis; Cell Differentiation; Cell Line, Tumor; Humans; Leukemia, Myeloid, Acute; Mitogen-Activated Protein Kinases; Ribonucleotides; Signal Transduction; Tumor Cells, Cultured | 2014 |